000

DAEWOONG PHARMA

No trades
See on Supercharts
Market capitalization
‪1.24 T‬KRW
‪121.74 B‬KRW
‪1.38 T‬KRW
‪4.33 M‬
Beta (1Y)
0.89

About DAEWOONG PHARMA

Headquarters
Hwaseong-si
Founded
2002
ISIN
KR7069620003
FIGI
BBG000C8L291
Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include general drugs, prescription drugs, health foods, medical devices, quasi drugs, and cosmetics. The company was founded on October 1, 2002 and is headquartered in Hwaseong-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 069620 is 111500 KRW — it has decreased by 0.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAEWOONG PHARMA stocks are traded under the ticker 069620.
DAEWOONG PHARMA is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
069620 stock is 1.36% volatile and has beta coefficient of 0.89. Check out the list of the most volatile stocks — is DAEWOONG PHARMA there?
069620 earnings for the last quarter are ‪1.58 K‬ KRW per share, whereas the estimation was ‪1.45 K‬ KRW resulting in a 8.95% surprise. The estimated earnings for the next quarter are ‪1.92 K‬ KRW per share. See more details about DAEWOONG PHARMA earnings.
DAEWOONG PHARMA revenue for the last quarter amounts to ‪303.00 B‬ KRW despite the estimated figure of ‪331.21 B‬ KRW. In the next quarter revenue is expected to reach ‪329.33 B‬ KRW.
Yes, you can track DAEWOONG PHARMA financials in yearly and quarterly reports right on TradingView.
069620 stock has risen by 3.15% compared to the previous week, the month change is a 12.14% fall, over the last year DAEWOONG PHARMA has showed a 5.09% increase.
069620 net income for the last quarter is ‪66.01 B‬ KRW, while the quarter before that showed ‪15.58 B‬ KRW of net income which accounts for 323.71% change. Track more DAEWOONG PHARMA financial stats to get the full picture.
Today DAEWOONG PHARMA has the market capitalization of ‪1.29 T‬, it has increased by 0.64% over the last week.
Yes, 069620 dividends are paid annually. The last dividend per share was 600.00 KRW. As of today, Dividend Yield (TTM)% is 0.53%. Tracking DAEWOONG PHARMA dividends might help you take more informed decisions.
DAEWOONG PHARMA dividend yield was 0.51% in 2023, and payout ratio reached 5.63%. The year before the numbers were 0.38% and 15.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 069620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAEWOONG PHARMA stock right from TradingView charts — choose your broker and connect to your account.
069620 reached its all-time high on Dec 22, 2020 with the price of 286500 KRW, and its all-time low was 14500 KRW and was reached on Jun 15, 2004.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAEWOONG PHARMA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAEWOONG PHARMA stock shows the sell signal. See more of DAEWOONG PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DAEWOONG PHARMA future price: according to them, 069620 price has a max estimate of 190000.00 KRW and a min estimate of 145000.00 KRW. Read a more detailed DAEWOONG PHARMA forecast: see what analysts think of DAEWOONG PHARMA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAEWOONG PHARMA EBITDA is ‪165.29 B‬ KRW, and current EBITDA margin is 11.91%. See more stats in DAEWOONG PHARMA financial statements.